Boehringer and Microsoft Partner to Explore Digital Patient Twins for Clinical Trials

The partnership aims to leverage digital twins to enhance the efficiency and accuracy of clinical trials.

Boehringer Ingelheim and Microsoft have formed a partnership to explore the use of digital patient twins in clinical trials. The digital twins will be used to simulate patient responses to treatments, allowing for more efficient and accurate trial design. This collaboration has the potential to accelerate the development of new treatments and improve patient outcomes.